CONTACT DETAILS

SCULPTRA & LANLUMA
AFTERCARE ADVICE

Sculptra or Lanluma is a synthetic, biocompatible and biodegradable injectable material known as Poly-L Lactic Acid (PLA) that stimulates the skin cells to manufacture more collagen, restoring lost volume and improving skin quality.

Aim of Treatment

When injected into the skin, Sculptra or Lanluma stimulates collagen helping to restore volume lost due to ageing, or a condition called facial lipoatrophy (loss of fat), and improve skin quality, tone and texture. Results are achieved gradually over a period of months.

COMMON SIDE EFFECTS

  • Pain or stinging sensation when the injection is performed.
  • Localised swelling, redness and or tenderness
  • Bleeding at the sites of injection
  • Rarely, bruising may be severe and may persist for several weeks.
  • Numbness or itching of the area following injection.
  • Tenderness post treatment

UNCOMMON SIDE EFFECTS

  • Infection
  • Inflammation
  • Skin discolouration (Infection or skin discolouration may occur within a few days, or weeks to months following treatment)
  • Allergic or sensitivity reaction, which may be local (redness, itching and rash at the site of treatment), or may be severe requiring hospital treatment.
  • Abscess formation
  • Prolonged swelling which may occur early or present after several weeks
  • Persistent lumps, nodules or papules, palpable but not visible which may take months or years to resolve.
  • Granuloma, an abnormal immune response which results in multiple nodules which may be visible and may require treatment to resolve, rarely nodules must be surgically removed.
  • Acne like formations
  • The blood supply to the skin may be interrupted by swelling or inadvertent injection into a vessel, causing pain, skin damage and possible scarring.
  • Though extremely rare, transient visual disturbance or permanent blindness has been reported following injectable cosmetic treatment.

BE AWARE

It is not always possible to achieve even or symmetrical correction.

Whilst not expected, it is possible that reactions described may inhibit your confidence to attend work or social events. You are advised to schedule treatment with this in mind, allowing time for common reactions such as bruising and swelling, to settle.

The general rule for quantity of treatment, longevity and frequency you will require to achieve the desired results, is as follows: 

  • Initial treatment 1 vial per decade of age e.g 40 = 4 vials, this is a guide only the number may be increased or decreased dependent upon individual needs.
  • The initial treatment will generally be over 3 to 4 treatment sessions which are 6 to 8 weeks apart.
  • Once the initial treatment is complete you will be invited for a review this will be 10 months after you commenced treatment, the review will establish if the treatment has achieved the desired results and further treatment can be commenced if required. This initial treatment should not require further treatment for 18 months.
  • After this initial period to maintain your results you should expect to return for treatment every 9 to 12 months for 1-2 vials per session.

 

1 Lanluma Vial = 2 Sculptra Vials

This cannot be interpreted as a fixed guarantee, but as an estimate based on manufacturer guidelines and clinical experience. It is possible that results will be achieved sooner and with less vials, or indeed that more will be required.

I understand treatments will be provided at 6 – 8 week intervals and should be undertaken as advised by my practitioner.  The successful outcome varies by degree and how long it lasts varies from one individual to another.

FOLLOWING TREATMENT

The poly-L-lactic acid is active for approx three months and in this initial stage following treatment the collagen is stimulated, dependent upon the area and the individual response to this stimulation small nodules can form, massage will help to prevent the nodules from forming ensuring even collagen formation.

The treatment area should be massaged for 5 minutes 5 times a day you are advised to use a massage gel which is suitable for the face, and commence the massage the morning after your treatment and you should continue to massage for 1 month post treatment.

Your practitioner will massage the area following treatment and will demonstrate the correct pressure, this should be gentle but firm, too much pressure can cause discomfort and nodule formation.

During the massage you should pay attention to the skin and if you do feel anything unusual or you have any concerns you should contact the clinic, adverse reactions can be managed more effectively with early intervention.  If you do develop small nodules these can be treated in clinic by your practitioner.

IMPORTANT SERIOUS SIDE EFFECT DISCLAIMER

Complications of granuloma formation cannot be treated in clinic, whilst this complication is rare, reported incidence 1 in 100 or 1%, MD Medical Aesthetics Ltd cannot be responsible for any additional costs incurred from outside medical specialists associated with this complication.  MD Medical Aesthetics Ltd can assist you in locating an appropriate Medical Specialist but will not be responsible for any further complications which are experienced as a result of treatment outside of this practice

CLINIC TERMS OF BUSINESS

I understand that though complications are uncommon, they do sometimes occur. It is possible that side effects not described may occur and indeed that a complication not previously reported may occur for the first time. I understand if I suffer any adverse reactions that are not expected, or concern me, I must contact my practitioner, and book a review appointment.  MD Medical Aesthetics Ltd cannot take responsibility for complications or results that have not been reported, assessed, documented and managed in a timely manner.  Whilst I have been advised of the probable result, this cannot be interpreted as a guarantee. Results vary from one individual to another.

I confirm that the medical health history form has been completed truthfully and I am fully aware that withholding medical information, including history of previous treatment, may be detrimental to the safe and optimal outcome of any treatment administered.  If there are any changes in my medical history, I must inform the practitioner.

I confirm that I have been provided with verbal and written information about this treatment which includes aftercare and follow up advice and I agree to follow the aftercare advice and understand this reduces risk of adverse reactions and helps ensure optimum results.

I understand information about me will be treated as confidential and access to it restricted in accordance with the Data Protection Act, unless specific permissions given.

By consenting to treatment you accept the clinic terms and conditions as outlined:

  • You are satisfied that the treatment has been explained comprehensively
  • That the possible risks and side effects associated with the treatment have been fully discussed and understood
  • That you have taken sufficient time to process and consider the information provided and any questions have been answered to your satisfaction, before making a decision to proceed with the agreed treatment plan.
  • You consent to your medical records being shared with appropriate professional staff
  • You accept emergency intervention treatment if required